The campaigner
01 February, 2013 by Tim DeanFollowing a 30-year stint heading up the Walter and Eliza Hall Institute, Sir Gustav Nossal is now a top level advisor helping to advance the cause of global health. Here he reflects on his long and fruitful career.
Victorian Infection and Immunity Network gets $300K injection from Vic government
30 January, 2013 by Tim DeanA collaborative network of researchers in infection and immunity has received a $300,000 grant from the Victorian government to encourage industry partnerships.
Mesoblast to head to phase III for stem cell treatment for spinal fusion
11 January, 2013 by Tim DeanPositive phase II results for Mesoblast’s (ASX:MSB) stem cell treatment for spinal fusion have prompted the company to look at moving to phase III this year.
Mesoblast MPCs used to boost blood cell transplants
13 December, 2012 by Dylan Bushell-EmblingScientists from Mesoblast (ASX:MSB) and the University of Texas have been trialling a method for using Mesoblast's adult stem cells to accelerate the body's adoption of umbilical cord blood stem cell transplants.
Product release: Malvern Zetasizer ZSP
27 November, 2012 by Staff WritersThe new Zetasizer Nano ZSP is designed for the measurement of size, mobility of proteins, zeta potential of nanoparticles and surfaces and microrheology of protein or polymer solutions.
Feature: Wired to think
12 November, 2012 by Graeme O'NeillAustralian neuroscientist Professor Seth Grant, FRS, is transforming neuroscience by revealing the startling complexity of the synaptic proteome.
Comment: How we developed the Hendra virus vaccine for horses
02 November, 2012 by Staff WritersDeborah Middleton, Senior Veterinary Pathologist at CSIRO, explains how she and her team developed the groundbreaking vaccine for the deadly Hendra virus.
Stem cell pioneers receive Nobel Prize
09 October, 2012 by Tim DeanTwo pioneers of stem cell science have received the Nobel Prize in Physiology or Medicine "for the discovery that mature cells can be reprogrammed to become pluripotent".
Iron ‘blueberries’ may be sign of microbial life on Mars
13 September, 2012 by Tim DeanIt’s unlikely anything lives on Mars today, but it may well have done so millions or billions of years past. And it may have left traces of its existence in the geology of the red planet. One such tantalising hint was discovered by the NASA Opportunity Rover, which found small spherical hematite balls, dubbed ‘blueberries,’ in the Martian soil.
Feature: Rush of blood
21 August, 2012 by Fiona WylieDr Benjamin Kile and Dr Emma Josefsson have helped solve a 100 year old mystery surrounding the short life of blood platelets and the role of a known cancer gene in blood cell formation.
Hendra relative could help combat the deadly virus
03 August, 2012 by Staff WritersA new benign virus related to Hendra and Nipah viruses could yield insights into what makes the latter deadly and open possibilities of new treatments or vaccines.
Feature: Silent epidemic
16 July, 2012 by Graeme O'NeillAboriginal children in the Northern Territory suffer from one of the world’s highest rates of otitis media – i.e. bacterial infections of the middle ear – which can lead to a lifetime of health problems.
Feature: Jill Banfield, extremophile
02 July, 2012 by Fiona WylieGeomicrobiology, environmental biogeochemistry, mineralogy, nanogeoscience, metagenomics, microbial community ecology and evolution. These are but some of the research interests of Professor Jill Banfield.
Slideshow: Lorne Infection and Immunity
04 April, 2012 by Tim DeanShots from the Lorne Infection and Immunity conference held in February this year.
Remember me: immune cell discovery could improve vaccines
02 April, 2012 by Tim DeanResearchers at the Walter and Eliza Hall Institute have revealed the process by which a specialised immune cell produces immune memory, which could lead to improvements in vaccines.
